NCT03611608View on ClinicalTrials.gov

A Study of LY3316531 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

August 30, 2018

Primary Completion Date

March 15, 2019

Study Completion Date

March 15, 2019

Conditions
Healthy
Interventions
DRUG

LY3316531

Administered IV

DRUG

Placebo

Administered IV

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician., Leuven

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT03611608 - A Study of LY3316531 in Healthy Participants | Biotech Hunter | Biotech Hunter